CBLB612
/ Zhejiang Hisun Pharmaceutical, Statera BioPharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 20, 2016
Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis
(clinicaltrials.gov)
- P2; N=23; Completed; Sponsor: BioLab 612 LLC; Active, not recruiting ➔ Completed
Clinical • Trial completion
May 20, 2016
Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis
(clinicaltrials.gov)
- P2; N=23; Active, not recruiting; Sponsor: BioLab 612 LLC
Clinical • New P2 trial
1 to 2
Of
2
Go to page
1